Disruption of intracellular communication facilitates breast tumour progression

Alterations in the levels of connexin expression in breast cancer appear to be relative rather than absolute. The heterogenicity of connexin expression may have functional implications for breast tumour progression. Pharmacological restoration of connexin 43 and 32 expression may therefore prove beneficial in cancer therapeutics.